申请人:Hoechst Aktiengesellschaft
公开号:US05215968A1
公开(公告)日:1993-06-01
Dipeptide derivatives having an enzyme inhibitory action Compounds of the formula I ##STR1## in which R.sup.1 represents a (substituted) heterocyclyl-alkyl, -alkoxy, -cycloalkyl or -cycloalkoxy and the corresponding heterocyclylmercapto radicals, A and B independently of one another denote an amino acid, R.sup.2 is hydrogen, alkyl, cycloalkyl, cycloalkyl-alkyl, aryl or aryl-alkyl, R.sup.3 represents hydrogen, alkyl, aryl, aryl-alkyl or hydroxyl and R.sup.4 denotes a radical (CH.sub.2).sub.0-4 CHR.sup.5 -D where R.sup.5 =hydrogen, alkyl, alkoxy, alkylthio, alkylamino, hydroxyl, azido or halogen and D=(substituted) heterocyclyl, have enzyme-inhibiting properties. Processes for the preparation of compounds of the formula I and their use in the treatment of hypertension and viral diseases are described.
具有酶抑制作用的二肽衍生物,其化合物的公式为I ##STR1## 其中,R.sup.1代表(取代)杂环基-烷基,-烷氧基,-环烷基或-环烷氧基及相应的杂环基硫醇基,A和B分别独立地表示氨基酸,R.sup.2表示氢,烷基,环烷基,环烷基-烷基,芳基或芳基-烷基,R.sup.3表示氢,烷基,芳基,芳基-烷基或羟基,而R.sup.4表示基(CH.sub.2).sub.0-4 CHR.sup.5 -D,其中R.sup.5=氢,烷基,烷氧基,烷硫基,烷基氨基,羟基,偶氮基或卤素,而D=(取代)杂环基,具有酶抑制性能。描述了制备公式I化合物的过程以及它们在治疗高血压和病毒性疾病中的用途。